Who Benefits from Plasma Donation?

07/22/2020

Plasma is the straw colored liquid portion of blood that remains after the red blood cells, platelets, and other components are taken out of blood. Plasma is actually the largest component of blood, at about 55%. Plasma is most commonly used in two ways: given directly to a recipient or used to create plasma-derived therapies. 

Plasma-derived therapies are used by many individuals in the rare disease community. These therapies are used to replace missing or deficient proteins, which are needed to maintain an immune system. Typically, someone who is getting plasma-derived therapies is reliant on them for life, meaning they get it regularly for the rest of their life to ensure they stay healthy. So, who needs plasma and plasma derived therapies?

Source Plasma

Source plasma is plasma collected from volunteers and used exclusively to make plasma derived therapies. Once the plasma derived therapies are created, they are used by rare disease patients. Here are the types of plasma derived therapies and the who uses them:

ALPHA-1 PROTEINASE INHIBITOR

Alpha-1 Antitrypsin Deficiency: A serious hereditary disorder which can result in life-threatening liver disease in children and adults and lung disease in adults.

IMMUNOGLOBULIN (Ig) REPLACEMENT THERAPY

Primary Immunodeficiency Diseases: A group of more than 400 rare, chronic disorders in which part of the body’s immune system is missing or functions improperly.

Idiopathic Thrombocytpenic Purpura (ITP): An autoimmune blood disorder that results in reduced blood platelet levels, essential for blood clotting.

Guillain-Barre Syndrome (GBS)/Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A a rare disorder in which your body's immune system attacks your nerves.

Kawasaki Disease: A condition that primarily affects children under the age of five and causes inflammation (swelling and redness) in blood vessels throughout the body.

Secondary Antibody Deficiencies (Cancer): A significant decrease in antibodies in the body.

Multisystem Inflammatory System in Children (MIS-C): A condition where different body parts can become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs.

COVID-19 Patients

C1 ESTERASE INHIBITOR (C1-INH)

Hereditary Angioedema: Caused by a missing C1 esterase inhibitor protein (C1-INH), which helps regulate inflammation.

BLOOD CLOTTING FACTORS

Hemophilia: A condition in which the ability of the blood to clot is severely reduced, causing the sufferer to bleed severely from even a slight injury.

Von Willebrand Disease: A a genetic disorder caused by missing or defective von Willebrand factor that causes excessive bleeding.

ALBUMIN

Certain Liver Conditions 

Burns 

Shock

Trauma

Convalescent Plasma 

Convalescent plasma is collected from patients who have recovered from a virus  and then used to help other patients and high risk individuals develop antibodies in the blood against the virus. The plasma is collected from volunteers and then used as a single donor transfusion or manufactured in to hyperimmune Ig (which is pooled from multiple donors, processed and standardized) and given to high risk individuals and other patients. The patient who receives the convalescent plasma gets a massive boost to their adaptive immune system, which provides passive immunity against the virus. 

Convalescent plasma collection is gaining in momentum at the moment due to the COVID-19 pandemic. Even celebrities such as Tom Hanks and Bryan Cranston have given convalescent plasma after recovering from coronavirus. 

Interested in becoming a plasma donor and helping out one of the rare disease communities or COVID-19 patients as listed above? To find a donation center near you, visit: www.plasmahero.org.

Join the Plasma Hero online community

Subscribe to Plasma Hero to get important news and updates that include hero stories and ways to get involved!

Sign up

News & Updates

Get the latest information on plasma through our news and updates. Featuring: Scientific discoveries, plasma supply, industry-related coverage, policy and legislation, and more!

Those with alpha-1 antitrypsin deficiency depend on plasma donations

07/16/2024

Many rare, chronic conditions with no known cures, including alpha-1 antitrypsin deficiency, can be managed with augmentation therapy treatments made from donated plasma.
Read More

Increase plasma supply by harmonizing state regulations

06/11/2024

States with regulations exceeding FDA standards create barriers for plasma centers, donors, and patients.
Read More

Plasma is a vital weapon against tetanus and rabies

05/20/2024

While tetanus and rabies are fairly rare in the United States today, these deadly diseases still pose a major global health threat. However, plasma-derived antibody products play a crucial role in treating these illnesses around the world.
Read More

Congressional Plasma Caucus formed to address concerns of constituents

04/25/2024

Members of the congressional Plasma Caucus provide a venue to educate legislators on important legislation to provide access to patients who rely on immunoglobulin (Ig) therapy.
Read More

Plasma demand is on the rise because of new patients and products

03/26/2024

The need for plasma is forecasted to increase since more patients are being diagnosed with current and newly discovered rare conditions as well as additional indications being approved for plasma medications.
Read More

Busting common plasma donation myths

02/21/2024

Misconceptions about plasma donation, such as that it is bad for your health, lead to undue misapprehensions.
Read More